4//SEC Filing
Bressi Jerome Charles 4
Accession 0000950170-25-004825
CIK 0001434316other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:06 PM ET
Size
5.5 KB
Accession
0000950170-25-004825
Insider Transaction Report
Form 4
Bressi Jerome Charles
See Remarks
Transactions
- Sale
Common Stock
2025-01-10$1.55/sh−5,980$9,269→ 270,203 total
Footnotes (2)
- [F1]Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,188 shares of Common Stock underlying RSUs granted to the Reporting Person on January 20, 2021 and 6,660 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through "sell to cover" transactions and do not represent discretionary trades by the Reporting Person.
- [F2]Represents the weighted average sale price of the shares sold ranging from $1.51 to $1.61 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0002034505
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:06 PM ET
- Size
- 5.5 KB